ArticleMedical science monitor : international medical journal of experimental and clinical research2021

Editorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic Monoclonal Antibody for Advanced Non-Small Cell Lung Cancer (NSCLC).

Dinah V ParumsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.